Opioid Antidote Naloxone Recalled

Pearl Mccarthy
June 7, 2018

There have not been reports of any adverse events as a result of using the Naloxone cartridge syringe, the release said.

The opioid overdose drug Naloxone has been recalled.

The risk is reduced by the possibility of detection, as the labeling contains a clear statement directing a visual inspection of the product for particulate matter and discoloration.

The recalled lots were distributed nationwide to wholesalers, distributors, and hospitals in the United States, Puerto Rico, and Guam from February 2017 to February 2018.

TvOS 12's Password autofill makes signing into Apple TV apps a breeze
So far its biggest advantage is its availability across all devices that are already on the latest version of the software. Apple's virtual assistant Siri will also make suggestions for notification settings based on which alerts people act upon.

"We're at 16 drug-related deaths so far and on track for another record year, with or without (naloxone)", Lycoming County Coroner Charles E. Kiessling Jr. said Tuesday. Patients who come into contact with the particulate matter may suffer from the following local irritation, allergic reactions, phlebitis, end-organ granuloma, tissue ischemia, pulmonary emboli, pulmonary dysfunction, pulmonary infarction, and toxicity.

Hospira is asking distributors and retailers to discontinue using and distributing the recalled product. There's a quick-acting antidote to save them called naloxone or Narcan. The drug is known to restore the respiration to a person who stops breathing due to the overdose.

Naloxone Hydrochloride is sold for IV use, intramuscular use and subcutaneous use. Nationwide, an estimated 60,000 people in the USA died from drug overdoses in 2016, more than gunshots or traffic accidents.

The products being recalled have the following lot numbers: 72680LL and 76510LL.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER